These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 25786392)

  • 1. Natural and synthetic compound anti-Trichomonas vaginalis: an update review.
    Vieira Pde B; Giordani RB; Macedo AJ; Tasca T
    Parasitol Res; 2015 Apr; 114(4):1249-61. PubMed ID: 25786392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-Trichomonas vaginalis activity of ursolic acid derivative: a promising alternative.
    Bitencourt FG; de Brum Vieira P; Meirelles LC; Rigo GV; da Silva EF; Gnoatto SCB; Tasca T
    Parasitol Res; 2018 May; 117(5):1573-1580. PubMed ID: 29572567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 20S Proteasome as a Drug Target in Trichomonas vaginalis.
    O'Donoghue AJ; Bibo-Verdugo B; Miyamoto Y; Wang SC; Yang JZ; Zuill DE; Matsuka S; Jiang Z; Almaliti J; Caffrey CR; Gerwick WH; Eckmann L
    Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31451503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro effects of various plants extracts on the growth of Trichomonas vaginalis.
    Sharafi SM; Yousefi M; Yousefi HA; Asghari G; Darani HY
    Infect Disord Drug Targets; 2013 Oct; 13(5):322-7. PubMed ID: 24712672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent developments in anti-Trichomonas research: An update review.
    Bala V; Chhonker YS
    Eur J Med Chem; 2018 Jan; 143():232-243. PubMed ID: 29175675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-Trichomonas vaginalis activity of synthetic lipophilic diamine and amino alcohol derivatives.
    Giordani RB; De Almeida MV; Fernandes E; França da Costa C; De Carli GA; Tasca T; Zuanazzi JA
    Biomed Pharmacother; 2009 Sep; 63(8):613-7. PubMed ID: 19013752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-Trichomonas vaginalis activity from triterpenoid derivatives.
    Innocente AM; Vieira Pde B; Frasson AP; Casanova BB; Gosmann G; Gnoatto SC; Tasca T
    Parasitol Res; 2014 Aug; 113(8):2933-40. PubMed ID: 24880238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medicinal plants and their isolated compounds showing anti-Trichomonas vaginalis- activity.
    Mehriardestani M; Aliahmadi A; Toliat T; Rahimi R
    Biomed Pharmacother; 2017 Apr; 88():885-893. PubMed ID: 28178618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and in vitro and in vivo biological evaluation of substituted nitroquinoxalin-2-ones and 2,3-diones as novel trichomonacidal agents.
    Ibáñez-Escribano A; Reviriego F; Nogal-Ruiz JJ; Meneses-Marcel A; Gómez-Barrio A; Escario JA; Arán VJ
    Eur J Med Chem; 2015 Apr; 94():276-83. PubMed ID: 25771033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitrichomonal activity and docking analysis of thiazole derivatives as TvMP50 protease inhibitors.
    Mena-Rejón G; Pérez-Navarro Y; Torres-Romero JC; Vázquez-Carrillo L; Carballo RM; Arreola R; Herrera-España Á; Arana-Argáez V; Quijano-Quiñones R; Fernández-Sánchez JM; Alvarez-Sánchez ME
    Parasitol Res; 2021 Jan; 120(1):233-241. PubMed ID: 33073325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening and bioguided fractionation of Amaryllidaceae species with anti-Trichomonas vaginalis activity.
    Vieira Pde B; Giordani RB; De Carli GA; Zuanazzi JA; Tasca T
    Planta Med; 2011 Jul; 77(10):1054-9. PubMed ID: 21308614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Challenges and Persistent Questions in the Treatment of Trichomoniasis.
    de Brum Vieira P; Tasca T; Secor WE
    Curr Top Med Chem; 2017; 17(11):1249-1265. PubMed ID: 27697044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trichomoniasis and its treatment.
    Nanda N; Michel RG; Kurdgelashvili G; Wendel KA
    Expert Rev Anti Infect Ther; 2006 Feb; 4(1):125-35. PubMed ID: 16441214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trichomoniasis: evaluation to execution.
    Harp DF; Chowdhury I
    Eur J Obstet Gynecol Reprod Biol; 2011 Jul; 157(1):3-9. PubMed ID: 21440359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-Trichomonas vaginalis activity of chalcone and amino-analogues.
    Trein MR; Rodrigues E Oliveira L; Rigo GV; Garcia MAR; Petro-Silveira B; da Silva Trentin D; Macedo AJ; Regasini LO; Tasca T
    Parasitol Res; 2019 Feb; 118(2):607-615. PubMed ID: 30535524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic activities of nitrothiazoles against trichomonads.
    Hof H; Müller KM; Schrank W; Schweizer EH; Zak O
    Arzneimittelforschung; 1987 Mar; 37(3):306-9. PubMed ID: 3496102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence, incidence, natural history, and response to treatment of Trichomonas vaginalis infection among adolescent women.
    Van Der Pol B; Williams JA; Orr DP; Batteiger BE; Fortenberry JD
    J Infect Dis; 2005 Dec; 192(12):2039-44. PubMed ID: 16288365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A review study on the anti-trichomonas activities of medicinal plants.
    Hashemi N; Ommi D; Kheyri P; Khamesipour F; Setzer WN; Benchimol M
    Int J Parasitol Drugs Drug Resist; 2021 Apr; 15():92-104. PubMed ID: 33610966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Review of Evidence-Based Care of Symptomatic Trichomoniasis and Asymptomatic Trichomonas vaginalis Infections.
    Meites E; Gaydos CA; Hobbs MM; Kissinger P; Nyirjesy P; Schwebke JR; Secor WE; Sobel JD; Workowski KA
    Clin Infect Dis; 2015 Dec; 61 Suppl 8(Suppl 8):S837-48. PubMed ID: 26602621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro trichomonacidal activity and preliminary in silico chemometric studies of 5-nitroindazolin-3-one and 3-alkoxy-5-nitroindazole derivatives.
    Ibáñez-Escribano A; Nogal-Ruiz JJ; Gómez-Barrio A; Arán VJ; Escario JA
    Parasitology; 2016 Jan; 143(1):34-40. PubMed ID: 26525913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.